The Wisdom of Warren Buffett
Warren Buffett’s timeless advice rings true: be fearful when others are greedy and greedy when others are fearful. How can we gauge the fear factor in a stock? Enter the Relative Strength Index (RSI), a tool that measures momentum from 0 to 100. A stock is deemed oversold when its RSI dips below 30.
Takeda Pharmaceutical’s Oversold Conditions
On Thursday, Takeda Pharmaceutical Co Ltd (Symbol: TAK) ventured into oversold territory, with the RSI plummeting to 29.9 as shares traded as low as $13.46 each. By contrast, the S&P 500 ETF (SPY) presently boasts an RSI of 50.4. A savvy investor might interpret TAK’s RSI of 29.9 as a signal that the recent wave of selling is running out of steam, hinting at potential buying opportunities on the horizon. The chart below illustrates TAK’s one-year stock performance:
Delving further, TAK’s 52-week low stands at $13.19 per share, while the high rests at $17.15 — a context against its recent closing price of $13.48.
Curious about 9 other oversold stocks worth exploring? Find out here »
Additional Resources:
TUSK Average Annual Return
Top Ten Hedge Funds Holding THD
FXNC Videos
The perspectives and insights shared here represent the author’s own and may not necessarily align with those of Nasdaq, Inc.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
